TCIM
WGSWW

TOMS Capital Investment Management’s GeneDx Holdings Warrant WGSWW Stock Holding History

TOMS Capital Investment Management’s Portfolio WGSWW Stock Details WGSWW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-353,164
Closed -$3.9M – 51
2020
Q4 		$3.9M Buy
+353,164
New +$888K 0.31% 22

Other funds holding WGSWW

SM
SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return
AC
Athanor Capital New York $24.6M AUM 2.49% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.46% 1-Year Est. Return
ICM
Ionic Capital Management New York $690M AUM 70.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
MCM
Moore Capital Management New York $6.74B AUM 45.86% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

TOMS Capital Investment Management's WGSWW Position: Q1 2021 in Review

TOMS Capital Investment Management sold out of GeneDx Holdings Warrant (WGSWW) in Q1 2021, closing a stake of 353,164 shares — an estimated $3.9M sold.

TOMS Capital Investment Management first reported a position in WGSWW in Q4 2020 and held it in 1 quarter. The position peaked at $3.9M in Q4 2020. 28 funds tracked by Wall St. Rank hold WGSWW as of Q1 2021.

  • TOMS Capital Investment Management reported no remaining GeneDx Holdings Warrant position as of Q1 2021 after selling out during the quarter.
  • TOMS Capital Investment Management sold 353,164 GeneDx Holdings Warrant shares in Q1 2021, an estimated $3.9M.
  • TOMS Capital Investment Management first reported a position in GeneDx Holdings Warrant in Q4 2020 and held it in 1 quarter.
  • TOMS Capital Investment Management's GeneDx Holdings Warrant position peaked at $3.9M in Q4 2020.
  • 28 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q1 2021.

Based on TOMS Capital Investment Management's 13F filing for Q1 2021, filed 17 May 2021.